KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Short-Term Debt issuances (2017 - 2018)

Neogenomics (NEO) has disclosed Short-Term Debt issuances for 7 consecutive years, with $5.0 million as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Short-Term Debt issuances changed N/A year-over-year to $5.0 million, compared with a TTM value of $5.0 million through Dec 2019, down 66.67%, and an annual FY2018 reading of $15.0 million, up 500.96% over the prior year.
  • Short-Term Debt issuances was $5.0 million for Q4 2018 at Neogenomics, down from $10.0 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $10.0 million in Q2 2018 and bottomed at -$2.9 million in Q2 2014.
  • Average Short-Term Debt issuances over 3 years is $1.7 million, with a median of $287000.0 recorded in 2014.
  • The sharpest move saw Short-Term Debt issuances plummeted 334.5% in 2014, then surged 111211.11% in 2018.
  • Year by year, Short-Term Debt issuances stood at -$2.0 million in 2014, then dropped by 25.68% to -$2.5 million in 2017, then surged by 299.92% to $5.0 million in 2018.
  • Business Quant data shows Short-Term Debt issuances for NEO at $5.0 million in Q4 2018, $10.0 million in Q2 2018, and -$2.5 million in Q3 2017.